Michael Link
Publication Details
-
High-dose methotrexate in osteogenic sarcoma adjuvant chemotherapy and limb salvage results.
Cancer Treat Rep. 1981: 99-106
This communication provides a description and update of the three adjuvant regimens utilized at the Sidney Farber Cancer Institute. The disease-free survivals are: Study I--42% at 4 years; Study II--58% at 3 years; and Study III--currently 78%. In the limb salvage experience, among the evaluable patients, 6 of 12 treated with preoperative chemotherapy are disease free (median 32 months) and 12 of 14 (86%) treated without preoperative chemotherapy are disease free (median 13 months).
Help
Trial Administration